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CASE REPORT
A 38-year-old Italian male restaurant proprietor underwent mitral valve replacement for rheumatic calcific mitral stenosis and regurgitation on 13 January 1972, with insertion of a No. 3 Starr Edwards mitral valve prosthesis type 6520. On the fourth day after the operation he developed a pyrexia with a rigor. Blood cultures taken at this time were sterile but it was known that at least one bottle of intravenous fluid he had received was contaminated with Pseudomonas thomasii (Phillips, Eykyn, and Laker, 1972) and he was accordingly treated with a six-week course of co-trimoxazole to which the organism was known to be sensitive. Following this, the patient made a good recovery and remained well for 10 months, requiring only routine maintenance doses of digoxin and warfarin.
In November 1972, he developed a febrile illness with rigors and complained of cough and abdominal pain, and one week later he became progressively dyspnoeic on exertion and orthopnoeic. Blood was taken for culture and treatment was started with amoxycillin. However, his fever persisted and he developed left heart failure, requiring admission to St. Peter's Hospital, Chertsey on 21 November. Amoxycillin was discontinued and further blood cultures were taken. He was transferred to St. Thomas' Hospital on 25 November where more blood cultures were taken before treatment was begun with intravenous ampicillin and intramuscular streptomycin as it was considered that he had endocarditis. Two days later a slow-growing oxidase-positive Gram-negative bacillus was isolated from the blood cultures taken at Chertsey. It was strongly suspected that this organism might be Ps. thomasii and the antibiotic therapy was changed to intravenous cephalexin, trimethoprim, and sulphadiazine. However, the patient's condition deteriorated and cardiac catheterization with angiography was performed on 29 November. Right heart catheterization showed a right atrial mean pressure of 6 mmHg, pulmonary artery pressure of 40/28 mmHg, and pul- (Henderson, 1973) . The majority of these cases are diagnosed by serology and do not have positive blood cultures. Where brucellae are recovered from the blood they are nearly always Br. abortus. Br. melitensis is rare in the United Kingdom but it is more readily isolated from the blood than Br. abortus. In the past 10 years, 24 cases of Br. melitensis infection with positive blood cultures have been reported to the Public Health Laboratory Service and only one of these was biotype 3. In every case the infection was acquired abroad (Payne, 1973) .
Endocarditis is a well recognized though rare complication of brucellosis and only four bacteriologically proven cases have been reported in the United Kingdom (Bassett-Smith, 1906; Rennie and Young, 1936; Hart, Morgan, and Lacey, 1951; Grant and Stote, 1953) . The world-wide incidence of brucella endocarditis is much more difficult to assess as reports vary. Vogler, Dorney, and Bridges (1962) reported one case of Br. suis endocarditis in a review of 148 cases of endocarditis seen since 1948 in the Department of Medicine, Emory University Medical School, Atlanta. Jones (1950) , in a review of world literature on bacterial endocarditis of non-streptococcal origin between 1936 and 1948, reported 15 cases due to brucellosis in a total of 212 patients. Giunchi, Pusic, and Tamburello (1951) found four cases of endocarditis in 150 patients with Malta fever, and Hardy (1943) reported a 1% incidence of endocarditis in patients with brucellosis. DalrympleChampneys (1950) , on the other hand, reported no case of endocarditis in 978 cases of undulant fever though he refers to one case each of pericarditis and myocarditis.
The morbidity of human brucellosis is considerable but the mortality is very low. However, the most frequent cause of death in patients with the disease is congestive cardiac failure resulting from endocarditis. Peery and Belter (1960) , in an exten-sive review of the world literature, found that in 44 cases of bacteriologically proven fatal brucellosis endocarditis was present at necropsy in 35 (80%). It is interesting to note that brucella endocarditis appears to be exclusively a disease of males. Fratini and Milli (1968) suggest that brucella endocarditis can be either primary, in which the infection occurs on a previously healthy valve, or secondary, in which it occurs on a valve that is abnormal, most commonly as a result of previous rheumatic fever. In the primary form the infection usually involves the aortic valve and in the secondary form the mitral valve is most commonly affected. Br. abortus in particular appears to have a specific though not exclusive affinity for the aortic valve.
Brucella endocarditis is therefore a rare disease, whether occurring on a previously healthy valve or on one already the seat of pathology. However, there is only one reported case in the world literature of brucella endocarditis involving a prosthetic valve. Ehrenhaft (1967) described a 23-year-old male packing house worker who contracted brucellosis, for which he was treated, but who, two months later was found to have endocarditis with Br. suis type 3 growing in the blood. Despite further treatment relapse occurred, and aortic valve replacement was undertaken for progressive cardiac failure from aortic regurgitation. The patient died 38 days after operation and at necropsy fresh vegetations were seen obstructing the prosthesis. Br. suis type 3 was cultured from these vegetations. In this case the patient was already infected with brucellae before insertion of the prosthetic valve. The patient we have described was entirely well for ten months following the original mitral valve replacement and would seem to be the first case of brucella endocarditis arising de novo on a prosthetic heart valve. It is of particular interest that emergency valve replacement followed by a prolonged course of co-trimoxazole produced a successful outcome since the mortality of endocarditis of any aetiology on prosthetic valves is 72% (Shafer and Hall, 1970) .
Although it was not conclusively proven that the cheese was the source of the brucella infecting this patient, this is extremely likely. It is known that Br. melitensis infection is widespread in sheep in central Italy and cheese made from sheep's milk is recognized as an important source of human infection (Cariello and Tursi, 1964 The combination of tetracycline with streptomycin is generally accepted as the standard treatment for acute brucellosis. However, brucellae are highly sensitive to the combination of trimethoprim with sulphamethoxazole (co-trimoxazole) and this drug has been found to be very effective clinically in Br. melitensis infection provided treatment is continued for six weeks (Hassan et al., 1971) . It was felt that in this patient prolonged antimicrobial therapy was indicated to protect the prosthetic valve which had been inserted in the presence of uncontrolled infection and that co-trimoxazole would therefore be easier to administer than the more traditional combination. This treatment seems to have been effective and has been completely free from side effects.
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